APA (7th ed.) Citation

Gayen, S., Pescatore, J., Bittner, M., Naranjo, M., Criner, G. J., Weaver, S., & Group, T. L. C. P. V. D. W. Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension. BMC.

Chicago Style (17th ed.) Citation

Gayen, Shameek, Jay Pescatore, Matthew Bittner, Mario Naranjo, Gerard J. Criner, Sheila Weaver, and Temple Lung Center Pulmonary Vascular Disease Working Group. Development of the Pulmonary Fibrosis, Pulmonary Vascular Resistance, Six Minute Walk Distance, B-type Natriuretic Peptide, Age (PVD-B65) Risk Score for Patients with Chronic Lung Disease and Pulmonary Hypertension. BMC.

MLA (9th ed.) Citation

Gayen, Shameek, et al. Development of the Pulmonary Fibrosis, Pulmonary Vascular Resistance, Six Minute Walk Distance, B-type Natriuretic Peptide, Age (PVD-B65) Risk Score for Patients with Chronic Lung Disease and Pulmonary Hypertension. BMC.